Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 350 of 1463 entries
View as:

Submucosal Saline Injection Followed by Endoscopic Ultrasound

Phase: N/A Priority: Normal
NCT ID: NCT06022978 Org: User:
Start: 01/01/21 End: 12/30/24 Due: 12/30/25

Liposomal Bupivacaine vs Ropivacaine for TAPBs

Phase: N/A Priority: Normal
NCT ID: NCT06430112 Org: User:
Start: 11/01/23 End: 06/30/24 Due: 06/30/25

Study to Evaluate the Efficacy and Safety of CDK4/6 Inhibitor SHR6390 Combined With Pyrotinib in the Treatment of HER2-positive Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03993964 Org: User:
Start: 08/15/19 End: 04/15/21 Due: 04/15/22

Safety and Efficacy of R-CMOP Versus R-CHOP in the Initial Treatment of DLBCL

Phase: N/A Priority: Normal
NCT ID: NCT06760039 Org: User:
Start: 01/10/25 End: 11/30/28 Due: 11/30/29

A Prospective, Open-label, Single-arm Clinical Study

Phase: N/A Priority: Normal
NCT ID: NCT04689087 Org: User:
Start: 04/01/20 End: 07/01/22 Due: 07/01/23

A Study to Evaluate Camrelizumab in Combination With Nb-Paclitaxel in Patients With Advanced or Metastatic NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT04167774 Org: User:
Start: 07/30/19 End: 09/30/22 Due: 09/30/23

Prognostic Nomogram of Extranodal NK/T-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04554511 Org: User:
Start: 08/28/20 End: 01/01/24 Due: 01/01/25

Diagnostic Performance of Deep Learning for Angle Closure

Phase: N/A Priority: Normal
NCT ID: NCT04242108 Org: User:
Start: 01/15/19 End: 03/31/22 Due: 03/31/23

HAIC Combined With Adebrelimab Plus Apatinib as the First-line Treatment for HCC in BCLC Stage C: An Open-label, Single-arm, Phase II Study

Phase: N/A Priority: Normal
NCT ID: NCT06482008 Org: User:
Start: 06/19/24 End: 02/01/26 Due: 02/01/27

Niraparib And Sintilimab In Recurrent/Metastatic Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05162872 Org: User:
Start: 08/05/21 End: 10/30/23 Due: 10/30/24

The Effect of Metformin in Patients With Newly Diagnosed mHSPC

Phase: N/A Priority: Normal
NCT ID: NCT04925063 Org: User:
Start: 06/16/21 End: 08/31/27 Due: 08/31/28

Cetuximab Plus Capecitabine as Maintenance Treatment in RAS and BRAF wt Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04262635 Org: User:
Start: 09/24/21 End: 08/30/24 Due: 08/30/25

Inetetamab Plus Cyclophosphamide Metronomic Chemotherapy Plus Aromatase Inhibitor in Metastatic HER2+/HR+ Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04941885 Org: User:
Start: 06/25/21 End: 07/01/25 Due: 07/01/26

A Real-World Study of COVID-19 Infection in Patients With Malignant Lymphomas Participating in Clinical Trials

Phase: N/A Priority: Normal
NCT ID: NCT05827341 Org: User:
Start: 12/01/22 End: 05/15/23 Due: 05/15/24

CEV With/Without Periocular Carboplatin Chemotherapy for Extraocular Retinoblastoma

Phase: N/A Priority: Normal
NCT ID: NCT02319486 Org: User:
Start: 01/31/09 End: 04/30/14 Due: 04/30/15

Efficacy and Safety of BMSCs (CG-BM1) for ACLF Patients

Phase: N/A Priority: Normal
NCT ID: NCT06740149 Org: User:
Start: 03/01/23 End: 01/31/26 Due: 01/31/27

Metformin Hydrochloride and Empagliflozin Tablets in the Treatment of Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT07003191 Org: User:
Start: 08/02/23 End: 12/31/25 Due: 12/31/26

Concurrent Chemotherapy for Recurrent T3/T4 Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04136886 Org: User:
Start: 01/01/20 End: 12/31/27 Due: 12/31/28

Induction Chemotherapy Sequential Sintilimab Combined With Dual Epigenetic Drugs for ENKTL-HLH

Phase: N/A Priority: Normal
NCT ID: NCT05008666 Org: User:
Start: 12/01/21 End: 04/30/23 Due: 04/30/24

Cryoablation Combined With Cardonilizumab and Bevacizumab in Hepatocellular Carcinoma With Pulmonary Metastases

Phase: N/A Priority: Normal
NCT ID: NCT06265350 Org: User:
Start: 02/02/24 End: 01/30/27 Due: 01/30/28

Metronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05342792 Org: User:
Start: 04/17/22 End: 06/30/29 Due: 06/30/30

Occurrence of Radiation-induced Otitis Media in Nasopharyngeal Carcinoma Patients After Intensity Modulated Radiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT06170021 Org: User:
Start: 12/18/23 End: 12/06/25 Due: 12/06/26

A Deep Learning Model for Diagnosing Lymph Node Metastasis in Nasopharyngeal Carcinoma(NPC)

Phase: N/A Priority: Normal
NCT ID: NCT06829147 Org: User:
Start: 11/19/24 End: 09/01/26 Due: 09/01/27

Quantitative Evaluation of Parafoveal Microvasculature Changes in Eyes With Exudative Circumscribed Choroidal Haemangioma: An Optical Coherence Tomography Angiography Study

Phase: N/A Priority: Normal
NCT ID: NCT04449900 Org: User:
Start: 03/01/17 End: 05/30/20 Due: 05/30/21

Sintilimab Combined With Chemotherapy and Radiotherapy in Newly Diagnosed Metastatic Nasopharyngeal Carcinoma: A Multicenter Study

Phase: N/A Priority: Normal
NCT ID: NCT05417139 Org: User:
Start: 07/01/22 End: 07/01/25 Due: 07/01/26